Monica Binaschi

2.3k total citations
72 papers, 1.8k citations indexed

About

Monica Binaschi is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Monica Binaschi has authored 72 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 31 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Monica Binaschi's work include Cancer therapeutics and mechanisms (28 papers), Histone Deacetylase Inhibitors Research (10 papers) and Protein Degradation and Inhibitors (9 papers). Monica Binaschi is often cited by papers focused on Cancer therapeutics and mechanisms (28 papers), Histone Deacetylase Inhibitors Research (10 papers) and Protein Degradation and Inhibitors (9 papers). Monica Binaschi collaborates with scholars based in Italy, United States and Spain. Monica Binaschi's co-authors include Giovanni Capranico, Franco Zunino, Daniela Fattori, Marina Porcelloni, Marielle Paris, Carlo Alberto Maggi, Mario Bigioni, Cristina Goso, Fabio Animati and Manlio Palumbo and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Monica Binaschi

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Binaschi Italy	22	1.4k	615	475	217	182	72	1.8k
Cristina Geroni Italy	24	1.0k 0.8×	508 0.8×	453 1.0×	128 0.6×	104 0.6×	76	1.6k
Stella Tinelli Italy	27	1.6k 1.2×	1.1k 1.9×	343 0.7×	359 1.7×	295 1.6×	51	2.3k
Valentina Zuco Italy	27	1.8k 1.3×	579 0.9×	420 0.9×	401 1.8×	176 1.0×	70	2.4k
Ryoji Ishida Japan	23	2.0k 1.5×	680 1.1×	365 0.8×	169 0.8×	373 2.0×	49	2.4k
Nives Carenini Italy	27	1.4k 1.0×	934 1.5×	452 1.0×	199 0.9×	196 1.1×	62	2.1k
Denzil Bernard United States	26	1.6k 1.2×	836 1.4×	737 1.6×	204 0.9×	61 0.3×	40	2.5k
Baguley Bc New Zealand	19	722 0.5×	426 0.7×	199 0.4×	276 1.3×	106 0.6×	38	1.2k
Kiyohiro Nishikawa Japan	21	767 0.6×	397 0.6×	348 0.7×	150 0.7×	70 0.4×	56	1.4k
Swee Y. Sharp United Kingdom	25	2.0k 1.5×	750 1.2×	417 0.9×	198 0.9×	124 0.7×	45	2.8k
Dale Grabowski United States	22	1.1k 0.8×	650 1.1×	157 0.3×	106 0.5×	97 0.5×	67	1.4k

Countries citing papers authored by Monica Binaschi

Since Specialization

Citations

This map shows the geographic impact of Monica Binaschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Binaschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Binaschi more than expected).

Fields of papers citing papers by Monica Binaschi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Binaschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Binaschi. The network helps show where Monica Binaschi may publish in the future.

Co-authorship network of co-authors of Monica Binaschi

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Binaschi. A scholar is included among the top collaborators of Monica Binaschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Binaschi. Monica Binaschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zicari, Sonia, Giuseppe Merlino, Alessio Fiascarelli, et al.. (2024). The Dual PIM/FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3‐ITD‐Mutant Acute Myeloid Leukaemia. Journal of Cellular and Molecular Medicine. 28(23). e70235–e70235. 1 indexed citations

Bardia, Aditya, Javier Cortés, François‐Clément Bidard, et al.. (2024). Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR1 -Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups. Clinical Cancer Research. 30(19). 4299–4309. 33 indexed citations

Merlino, Giuseppe, Alessio Fiascarelli, Patrizia Tunici, et al.. (2023). Abstract 2849: The oral SERD Elacestrant in combination with the PI3K inhibitor MEN1611 inhibits tumor growth in ER+/HER2- breast cancer in vitro and in PDX models. Cancer Research. 83(7_Supplement). 2849–2849. 1 indexed citations

Papoff, Giuliana, Dario Presutti, Stefano Alemà, et al.. (2023). The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway. Frontiers in Oncology. 13. 1283951–1283951. 2 indexed citations

Merlino, G., Mario Bigioni, Patrizia Tunici, et al.. (2021). 489P MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts. Annals of Oncology. 32. S573–S573. 2 indexed citations

Colangelo, Tommaso, Alessandra Fucci, Carolina Votino, et al.. (2013). MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer. Neoplasia. 15(9). 1086–1099. 129 indexed citations

Cipollone, Amalia, Marielle Paris, Marina Porcelloni, et al.. (2013). Benzofused hydroxamic acids: Useful fragments for the preparation of histone deacetylase inhibitors. Part 1: Hit identification. Bioorganic & Medicinal Chemistry Letters. 23(14). 4091–4095. 7 indexed citations

Bigioni, Mario, Patrizia Felicetti, Cristina Rossi, et al.. (2012). Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures. Bioorganic & Medicinal Chemistry Letters. 22(17). 5360–5362. 11 indexed citations

Binaschi, Monica, Cecilia Simonelli, Cristina Goso, Mario Bigioni, & Carlo Alberto Maggi. (2011). Maintenance therapy in ovarian cancer: Molecular basis and therapeutic approach. Experimental and Therapeutic Medicine. 2(2). 173–180. 5 indexed citations

10.

Rossi, Cristina, Marina Porcelloni, Mario Bigioni, et al.. (2011). 4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(22). 6767–6769. 6 indexed citations

11.

Binaschi, Monica, Maurizio Gianni’, Carlo Alberto Maggi, et al.. (2010). Antiproliferative and Differentiating Activities of a Novel Series of Histone Deacetylase Inhibitors. ACS Medicinal Chemistry Letters. 1(8). 411–415. 74 indexed citations

12.

Bigioni, Mario, Carlo Alberto Maggi, Stefano Manzini, et al.. (2007). Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft. Cancer Chemotherapy and Pharmacology. 62(4). 621–629. 19 indexed citations

13.

Animati, Fabio, Mario Bigioni, Monica Binaschi, et al.. (2007). Synthesis, Biological Evaluation, and Molecular Modeling Studies of Rebeccamycin Analogues Modified in the Carbohydrate Moiety. ChemMedChem. 3(2). 266–279. 17 indexed citations

14.

Maggi, Carlo Alberto, et al.. (2005). NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780.. PubMed. 27(3). 799–806. 16 indexed citations

15.

Sacco, G. G., Stefano Evangelista, Marco Criscuoli, et al.. (2005). Involvement of nitric oxide in both central and peripheral haemodynamic effect of d/l-nebivolol and its enantiomers in rats. European Journal of Pharmacology. 511(2-3). 167–174. 12 indexed citations

16.

Binaschi, Monica, et al.. (2002). Nuclear factor‐κB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity. International Journal of Cancer. 102(5). 476–482. 7 indexed citations

17.

Pourquier, Philippe, Stella Tinelli, Monica Binaschi, et al.. (1999). Topoisomerase Poisoning Activity of Novel Disaccharide Anthracyclines. Molecular Pharmacology. 56(1). 77–84. 54 indexed citations

18.

Binaschi, Monica, Giovanni Capranico, Laura Dal Bo, & Franco Zunino. (1997). Relationship between Lethal Effects and Topoisomerase II-Mediated Double-Stranded DNA Breaks Produced by Anthracyclines with Different Sequence Specificity. Molecular Pharmacology. 51(6). 1053–1059. 76 indexed citations

19.

Binaschi, Monica, Rosanna Supino, Romolo A. Gambetta, et al.. (1995). MRP gene overexpression in a human doxorubicin‐resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross‐resistance. International Journal of Cancer. 62(1). 84–89. 35 indexed citations

20.

Pratesi, Graziella, Giovanni Capranico, Monica Binaschi, et al.. (1990). Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug‐induced DNA alterations in two human small‐cell lung cancer xenografts. International Journal of Cancer. 46(4). 669–674. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact